Table 1.
Clinicopathological information of the lung adenocarcinoma PROSPECT set used for STAT3 mRNA analysis
Covariate | Covariate categories | Frequency (percentage) |
---|---|---|
Race | African American | 8 (5.3%) |
Asian | 6 (4.0%) | |
Hispanic | 5 (3.3%) | |
Caucasian | 131 (87.3%) | |
Tobacco history | No | 19 (12.7%) |
Yes | 131 (87.3%) | |
Smoking status | Never | 19 (12.7%) |
Former | 67 (44.7%) | |
Current | 64 (42.6%) | |
Gender | Female | 73 (48.7%) |
Male | 77 (51.3%) | |
Stage | I | 90 (60.0%) |
II | 24 (16.0%) | |
III | 35 (23.3%) | |
IV | 1 (0.7%) | |
KRAS | Wild type | 111 (74.0%) |
Mutant | 39 (26.0%) | |
Recurrence | No | 89 (59.3%) |
Yes | 61 (40.7%) |